Preclinical evaluations of therapies combining the vascular targeting agent combretastatin A-4 disodium phosphate and conventional anticancer therapies in the treatment of Kaposi's sarcoma

Lingyun Li, Amyn M. Rojiani, Dietmar W. Siemann

Research output: Contribution to journalArticlepeer-review

49 Scopus citations

Fingerprint Dive into the research topics of 'Preclinical evaluations of therapies combining the vascular targeting agent combretastatin A-4 disodium phosphate and conventional anticancer therapies in the treatment of Kaposi's sarcoma'. Together they form a unique fingerprint.

Medicine & Life Sciences